6Farhat BA, Marinos G, Daniels HM, et al. Evaluation of efficacy and safety of thymus humoral factor-gamma 2 in the management of chronic hepatitis B[J]. J Hepatol, 1995,23 (1): 21-27.
7Zeuzem S, Carreno V. Interleukin-12 in the treatment of chronic hepatitis B and C[J]. Antiviral Res, 2001,52 (2) : 181- 188.
8Liaw YF. Management of patients with chronic hepatitis B[J]. J Gastroenterol Hepatol, 2002,17 (4) : 406-408.
9Delaney W4h, Bartholomeusz A, Lgcarnini SA. Evoling therapies for the treatment of chronic hepatitis B virus infeetion[J]. Expert Opin Investig Drugs, 2002, 11 (2):169- 187.
10Tsai SL, Sheen IS, Chien RN, et al. Activation of Th1 immunity is a common immune mechanism for the successful treatment of hepatitis B and C: tetramer assay and therapeutic implications[J]. J Biomed Sci, 2003,10(1) : 120-135.
